E
PDS Biotechnology Corporation PDSB
$1.27 $0.0252.02% NASDAQ
Recommendation
Prev Close
$1.24
Volume
99,497
Avg Vol (90D)
524,549
Market Cap
$56.29M
Dividend & Yield
--
52-Week Range
$0.8505 - $4.42
P/E (TTM)
--
EPS (TTM)
-$1.04
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
PDS Biotechnology (PDSB) Price Target Cut by B. Riley Amid Strategic Focus Shift PDSB Stock News
4/25/2025 - GuruFocus
PDS Biotechnology price target lowered by $2 at B. Riley, here's why
4/25/2025 - The Fly
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
4/23/2025 - Globe Newswire
PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025 Annual Meeting
4/16/2025 - Globe Newswire
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
4/8/2025 - Globe Newswire
PDS Biotech's Earnings Call Highlights: Clinical Progress Amid Funding Challenges
3/29/2025 - TipRanks Financial Blog
PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
3/28/2025 - GuruFocus
Q4 2024 PDS Biotechnology Corp Earnings Call Transcript
3/28/2025 - GuruFocus
PDS Biotechnology (PDSB) Posts Earnings Beat, Reports Strong Cash Position
3/27/2025 - GuruFocus
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss Retail Stays Bearish
3/27/2025 - Stocktwits News Feed
PDS Biotech Advances Cancer Immunotherapy with New Clinical Trial
3/27/2025 - TipRanks Financial Blog
PDS Biotechnology price target lowered to $13 from $21 at H.C. Wainwright
3/27/2025 - TipRanks Financial Blog
PDS Biotechnology price target lowered by $8 at H.C. Wainwright, here's why
3/27/2025 - The Fly
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call Transcript
3/27/2025 - Seeking Alpha: Transcripts
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call Transcript
3/27/2025 - SeekingAlpha
PDS Biotechnology (NASDAQ:PDSB) Posts Earnings Results
3/27/2025 - Ticker Report
PDS Biotechnology GAAP EPS of -$1.03 beats by $0.08
3/27/2025 - SeekingAlpha.com: All News
PDS Biotechnology reports FY24 EPS ($1.03), consensus ($1.11)
3/27/2025 - The Fly
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
3/27/2025 - Globe Newswire
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
3/25/2025 - Globe Newswire
PDS Biotechnology (PDSB): Among the Penny Stocks With Huge Upside Potential According to Analysts
3/23/2025 - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts
3/22/2025 - Insider Monkey
Short Interest in PDS Biotechnology Co. (NASDAQ:PDSB) Grows By 20.7%
3/20/2025 - MarketBeat
PDS Biotechnology Co. (NASDAQ:PDSB) Sees Large Growth in Short Interest
3/19/2025 - Zolmax
PDS Biotechnology (PDSB) Expected to Announce Quarterly Earnings on Wednesday
3/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$36.26M
EBIT (TTM)
-$36.32M
Net Income (TTM)
-$37.61M
Balance Sheet
Total Assets (Q)
$45.36M
Total Debt (Q)
$21.83M
Total Liabilities (Q)
$26.35M
Book Value Per Share (Q)
$0.5003
Cash Flow
Cash from Operations (TTM)
-$35.03M
Cash from Investing (TTM)
-$29.00K
Cash from Financing (TTM)
$20.19M
Net Change in Cash (TTM)
-$14.87M
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.80
7-Day Total Return
17.13%
30-Day Total Return
-5.60%
60-Day Total Return
-22.87%
90-Day Total Return
-34.63%
Year to Date Total Return
-26.88%
1-Year Total Return
-62.68%
2-Year Total Return
-79.26%
3-Year Total Return
-77.12%
5-Year Total Return
33.16%
52-week Low
Apr 07, 2025 - $0.8505
52-week High
Jul 16, 2024 - $4.42
Valuation
Market Cap
$56.29M - Micro Cap
Enterprise Value
$36.43M
Price/Sales (TTM)
--
Price/Book (Q)
2.48
Dividends and Shares
Shares Outstanding
37.49M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pdsbiotech.com
Phone Number
800 208 3343
Address
303A College Road East
Princeton, NJ 08540
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company’s lead product candidate is Versamune HPV, which... more
NASDAQ 04/29/2025 3:45PM Eastern Quotes delayed